07:00 , May 21, 2012 |  BC Week In Review  |  Company News

Biogen Idec sales and marketing update

Biogen Idec launched Avonex Pen intramuscular autoinjector and Avostartgrip in the U.S. The single-use Avonex Pen, which is approved in the EU and Canada, is used for once-weekly delivery of the biotech's multiple sclerosis...
08:00 , Mar 5, 2012 |  BC Week In Review  |  Clinical News

Avonex Pen regulatory update

Biogen Idec said FDA approved its single-use Avonex Pen intramuscular autoinjector for the once-weekly delivery of the biotech's multiple sclerosis (MS) drug Avonex interferon beta-1a. The company said FDA also approved a new dose...
07:00 , Jun 13, 2011 |  BC Week In Review  |  Clinical News

Avonex Pen regulatory update

Biogen Idec said the European Commission approved its single-use Avonex Pen intramuscular autoinjector for the once-weekly delivery of multiple sclerosis (MS) drug Avonex interferon beta-1a. The company said it will launch the product in...
07:00 , Apr 25, 2011 |  BC Week In Review  |  Clinical News

Avonex Pen regulatory update

EMA's CHMP issued a positive opinion recommending approval of Biogen Idec's single-use Avonex Pen intramuscular autoinjector for the once-weekly delivery of multiple sclerosis (MS) drug Avonex interferon beta-1a. The company also said the product...